Its the triple action that distinguishes it, because most existing medications attack one or two pathways
alternative therapeutic options should be considered for these patients [seeBoxed WarningandUse in Specific Populations (8.1)]
Intranasal and intravenous routes have also been studied
The atherosclerotic benefits provided by GLP-1RA, which reflect the improvement of glycated hemoglobin level, blood pressure, albumin-to-creatinine ratio and other favorable hemodynamic effects, may be responsible, at least in part, for this finding
Your doctor will take these factors into consideration and suggest the dose and frequency thats right for you
This is based on trends observed in other drugs, including increased competition and regulatory pressures